
This study aimed to investigate the clinical and prognostic relevance of the Hippo‐YAP transactivators YAP1 and TAZ in oral squamous cell carcinoma, and their possible relationship with PI3K/mTOR pathway activation. Nuclear YAP1 is an independent predictor of poor survival in oral squamous cell carcinoma.
Like
Save
Share